PIEDMONT ROCKDALE HOSPITAL — History
CCN 110091 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$217M
Latest Revenue (FY2022)
+8.9%
Revenue CAGR (3yr)
-4.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $183M | $201M | $217M | +8.2% | +8.9% |
| Operating Expenses | $184M | $217M | $226M | +4.2% | +10.8% |
| Operating Margin | -0.6% | -8.2% | -4.1% | +49.5% | +0.0% |
| Net Income | $-1M | $-16M | $-9M | +45.4% | +0.0% |
| Licensed Beds | 141 | 141 | 141 | +0.0% | +0.0% |
| Total Patient Days | 47,456 | 53,460 | 51,339 | -4.0% | +4.0% |
| Medicare Day % | 20% | 18% | 16% | -9.6% | -9.8% |
| Medicaid Day % | 7% | 7% | 7% | +2.6% | -1.5% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +18.5% ($183M → $217M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.9%
This Hospital
+7.6%
State Avg
Latest Margin
-4.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $234M | -5.9% |
| FY2024 (proj) | $251M | -7.7% |
| FY2025 (proj) | $268M | -9.4% |